Pre-RDT | Transition | Post-RDT | P-value | |
---|---|---|---|---|
Patients (n, % of admissions) | 300 (80.4) | 282 (72.7) | 524 (69.3) | 0.33 |
Male Patients (n, %) | 125 (42.2) | 119 (42.5) | 231 (44.3) | 0.8 |
Age (median, IQR) | 4 (1.25, 16) | 9 (2.1, 21) | 7 (3, 18) | 0.27 |
<5 years | 157 (52.3) | 111 (39.36) | 216 (41.2) | 0.003 |
5–15 years | 57 (19.0) | 57 (20.2) | 148 (28.2) | |
>15 years | 86 (28.67) | 114 (40.43) | 160 (30.5) | |
Village (n, %) | ||||
Bordering Villages | 76 (26.6) | 90 (33.1) | 167 (33.2) | 0.12 |
Remote Villages | 46 (16.0) | 39 (14.6) | 38 (7.9) | <0.001 |
Comorbid diagnosis (n, %) | ||||
Any comorbidity | 150 (50.0) | 153 (54.3) | 144 (27.5) | <0.001 |
RTI/PNA | 104 (34.7) | 116 (41.1) | 94 (17.9) | <0.001 |
Diarrhea | 21 (7.0) | 12 (4.3) | 19 (3.6) | 0.08 |
Anti-malarial (n, %) | ||||
Intravenous | 263 (88.7) | 260 (92.2) | 486 (93.1) | 0.024 |
Oral only | 35 (11.7) | 19 (86.7) | 33 (6.3) | 0.012 |
Antibiotics | 225 (75.0) | 216 (76.6) | 279 (53.6) | <0.001 |
LOS (mean, SD) | 2.8 (1.3) | 2.5 (1.2) | 2.4 (1.0) | <0.001 |
Referred (n, %) | 21 (8.0 %) | 12 (4.5 %) | 16 (4.2 %) | 0.086 |